• Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices...
    37 KB (2,816 words) - 15:01, 4 April 2024
  • Thumbnail for Allergan, Inc.
    Allergan, Inc. was an American global pharmaceutical company focused on eye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement...
    14 KB (1,191 words) - 04:04, 10 June 2024
  • Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing...
    25 KB (2,046 words) - 15:25, 22 May 2024
  • + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He is the founder of special-purpose acquisition company (SPAC)...
    11 KB (972 words) - 14:40, 2 July 2024
  • million. On 25 June 2019, AbbVie announced it would acquire Irish-based Allergan plc for about $63 billion; however the transaction would not be structured...
    39 KB (3,327 words) - 02:23, 25 June 2024
  • Ian Pyott CBE (born 1953) was the CEO of Allergan, a pharmaceutical company from 1998 to 2015, when Allergan was acquired by Actavis. In 2014 he was one...
    20 KB (1,811 words) - 03:57, 30 June 2024
  • Thumbnail for Teva Pharmaceuticals
    [2] "Analyst cuts Allergan generics sales estimates as Teva deal close nears". FiercePharma.com. June 16, 2016. "Teva to Buy Allergan's Generic Drug Unit"...
    68 KB (5,680 words) - 20:57, 24 June 2024
  • Thumbnail for Linaclotide
    US and the European Union in 2012. It is marketed by Abbvie (formerly Allergan) in the United states and by Astellas in Asia;[citation needed] Ironwood...
    21 KB (1,620 words) - 04:36, 28 April 2024
  • Thumbnail for Diphenhydramine
    Diphenhydramine (redirect from Allergan B)
    Diphenhydramine (DPH) is an antihistamine and sedative mainly used to treat allergies, insomnia, and symptoms of the common cold. It is also less commonly...
    69 KB (6,166 words) - 14:42, 5 July 2024
  • link] "Allergan Accelerates Transformation to Branded Growth Pharma Leader by Divesting Global Generics Business to Teva for $40.5 Billion". Allergan. 27...
    30 KB (625 words) - 20:08, 6 February 2024